(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOPHOS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NOPHOS

ST13

US500000079219757

Class

5

Filing

79219757

Registration

5567692

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

07/23/2026

Trademark type

Word

Nice classes

5

Filing date

09/18/2017

Registration date

09/25/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2025

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

27

Owner location

AT

Examiner

EULIN, INGRID C

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MEDICE Arzneimittel GmbH

Representatives

Thomas J. Romano Kolitch Romano Dascenzo Gates LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for treating hyperphosphataemia

Publications

History of USPTO decisions and trademark events.

41 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/23/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

07/06/2026

INPC

INVALIDATION PROCESSED

07/06/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

12/11/2025

C71T

CANCELLED SECTION 71

04/11/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/25/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/06/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/06/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/06/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/06/2022

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

01/25/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/22/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/22/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/07/2019

FIMP

FINAL DISPOSITION PROCESSED

01/07/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/25/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/04/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

09/25/2018

GPNX

NOTIFICATION PROCESSED BY IB

07/20/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/10/2018

PUBO

PUBLISHED FOR OPPOSITION

07/10/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/04/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/04/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/20/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/04/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

05/31/2018

ALIE

ASSIGNED TO LIE

05/30/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/30/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

05/30/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/30/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/15/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/15/2018

RFNT

REFUSAL PROCESSED BY IB

01/27/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/11/2018

RFRR

REFUSAL PROCESSED BY MPU

01/11/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/22/2017

CNRT

NON-FINAL ACTION WRITTEN

12/21/2017

DOCK

ASSIGNED TO EXAMINER

12/20/2017

MAFR

APPLICATION FILING RECEIPT MAILED

11/07/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/03/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/02/2017

Continuous trademark protection

Get notified about every new filing that threatens NOPHOS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.